MTOR and melanoma: Only on Me23, the combination of PLX4720 with GDC-0941, or AZD8055 achieved synergistic growth inhibitory effect indicating that, for this particular melanoma, concurrent suppression of RAF/MAPK/ERK pathway is necessary to affect growth when only PI3K or mTOR signaling is abrogated.